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ABSTRACT
This study evaluated methylation patterns of long
interspersed nuclear element-1 (LINE-1) sequences
from 17 loci in several cell types, including squa-
mous cell cancer cell lines, normal oral epithelium
(NOE), white blood cells and head and neck squa-
mous cell cancers (HNSCC). Although sequences of
each LINE-1 are homologous, LINE-1 methylation
levels at each locus are different. Moreover, some
loci demonstrate the different methylation levels
between normal tissue types. Interestingly, in
some chromosomal regions, wider ranges of
LINE-1 methylation levels were observed. In cancer-
ous cells, the methylation levels of most LINE-1 loci
demonstrated a positive correlation with each other
and with the genome-wide levels. Therefore, the
loss of genome-wide methylation in cancerous
cells occurs as a generalized process. However,
different LINE-1 loci showed different incidences
of HNSCC hypomethylation, which is a lower methy-
lation level than NOE. Additionally, we report a
closer direct association between two LINE-1s in
different EPHA3 introns. Finally, hypermethylation
of some LINE-1s can be found sporadically in
cancer. In conclusion, even though the global hypo-
methylation process that occurs in cancerous cells
can generally deplete LINE-1 methylation levels,
LINE-1 methylation can be influenced differentially
depending on where the particular sequences are
located in the genome.
INTRODUCTION
Long interspersed nuclear element-1 (LINE-1 or L1)
sequences are highly repeated and widely interspersed
human retrotransposon sequences (1). LINE-1s constitute
about 17% of the human genome with up to 600000
copies present (2). Approximately 3000–4000 copies
remain in a full-length form and some may be retrotrans-
positionally active (3). By measuring the quantity of
LINE-1 methylation, we found that LINE-1 methylation
levels are varied. Whereas cancerous cells revealed a lower
percentage of methylation, their normal tissue counter-
parts, normal tissues from diﬀerent organs, showed
tissue-speciﬁc levels of methylated LINE-1s (4). The
levels of LINE-1 methylation were signiﬁcantly diﬀerent
among diﬀerent tissue types. Moreover, while the range of
LINE-1 methylation levels in some tissues was narrow,
some other tissues, such as the esophagus or thyroid, con-
tained widely distributed LINE-1 methylation levels (4).
The variation of methylation levels of LINE-1s in normal
tissues and the hypomethylation observed in cancerous
cells has been conﬁrmed by several studies (5–18). These
data indicate that the epigenetic event may be important
for cellular functions, not only in cancer, but also in
normal cells (4). Moreover, these ﬁndings led us to a ques-
tion of whether methylation patterns of each LINE-1 are
distinct despite the sequences being homologous.
In cancer, DNA methylation of the whole genome is
generally depleted and this event is called ‘global hypo-
methylation’ (19–21). The causal mechanism of global
hypomethylation is not known (22). Global hypomethyla-
tion may have several consequences on the multistep pro-
cess of carcinogenesis. The most commonly recognized
eﬀects are to facilitate chromosomal instability (23–25)
and to control gene expression (26). Interestingly, both
consequences have been proposed to occur ‘in cis’, on
nearby genomic sites of the hypomethylation (26–28).
Therefore, if each LINE-1 locus possesses distinct methy-
lation levels, LINE-1s may play diﬀerent roles in cellular
biology and cancer development, depending on their loca-
tions. This study evaluated the methylation status of
diﬀerent LINE-1s in normal cells and cancerous tissues.
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MATERIALS AND METHODS
Cells and tissue preparation
Eleven head and neck squamous cell cancer (HNSCC) cell
lines (WSU-HN) (29), including WSU-HN 4, 6, 8, 12, 13,
17, 19, 22, 26, 30 and 31, were provided by Dr Silvio
Gutkind (NIH, USA). HeLa (cervical cancer) and KB
(oral cancer cell line, but with a HeLa contaminant)
lines (ATCC, Manassas, VA, USA) were included. Cells
were cultured in Dulbecco’s modiﬁed Eagle’s medium
(Gibco BRL, Life Technologies, Pairly, UK), supplemen-
ted with 10% heat-inactivated fetal bovine serum
(Sigma, St Louis, MO, USA). Cells were incubated at
378Ci n5 %C O 2.
Normal oral epithelium (NOE) samples from 12
individuals were collected. Brieﬂy, each subject used
20ml of sterile 0.9% NaCl solution to rinse and gargle
for 15s then spit the solution into a sterile 50-ml closed
container, which was kept at 48C until the samples were
processed for DNA collection (within 24h of collection).
Cells from the oral rinses were collected by centrifugation
at 2500g for 15min at 48C. The supernatant was discarded
and the pellets were washed with sterile PBS. Several sam-
ples of white blood cells (WBCs) from normal, healthy
individuals were also collected. Several archival paraﬃn-
embedded tissues, derived from HNSCCs, were obtained
and prepared in 5mm thickness sections on slides for
microdissection as previously described (4).
COBRA PCR
Combined bisulﬁte restriction analysis (COBRA) (30) for
genome-wide LINE-1s (COBRALINE1) and COBRA
for unique L1 sequences (CU-L1) were both performed
as previously described, with some modiﬁcations (4).
LINE-1s were selected by blat using L1.2 sequence to
http://genome.ucsc.edu and full-length intronic LINE-1s
with the representative COBRALINE-1 CpG dinucleo-
tides were selected. All selected LINE-1s are listed in
Supplementary Table S1. After extraction, all DNA sam-
ples were treated with sodium bisulﬁte as previously
described (4,31). Brieﬂy, genomic DNA was denatured
in 0.22M NaOH for 10min at 378C. Thirty microliters
of 10mM hydroquinone and 520ml of 3M sodium bisul-
ﬁte were both added for 16–20h at 508C. The DNA was
puriﬁed and incubated in 0.33M NaOH for 5min at 258C,
ethanol-precipitated, then washed with 70% ethanol and
resuspended in 20ml of TE buﬀer. Two microliters of
bisulﬁted DNA were subjected to 35 cycles of PCR with
two primers, as listed in Supplementary Table S2, at an
annealing temperature of 538C. The amplicons were
digested in 30ml reaction volumes with 2U of TaqI or
8U of TasI in 1 TaqI buﬀer (MBI Fermentas) overnight
at 658C and then electrophoresed on 8% non-denaturing
polyacrylamide gels. The intensities of DNA fragments
were measured on a PhosphoImager, using the
ImageQuant software (Molecular Dynamics, GE Health-
care, Slough, UK). The TaqI positive methylated
amplicons yielded 80-bp DNA fragments, whereas the
TasI positive unmethylated amplicons resulted in 98-bp
fragments (previously reported as 97bp). The LINE-1
methylation level was calculated as a percentage (the
intensity of the TaqI-digested methylated LINE-1 frag-
ment divided by the sum of the TasI-digested unmethy-
lated LINE-1 and TaqI-positive amplicons). For CU-L1,
several other methylated and unmethylated digested
amplicons, as listed in Supplementary Table S2, were
also measured. The methylation levels among several
CpG dinucleotides were compared. All COBRA assays
were performed in duplicate. The same set of DNAs was
applied as positive controls in each set of the COBRA
experiments. The PCR products of some of the CU-L1
were cloned into the pGEM-T easy vector (Promega,
Santhan, UK) and sequenced.
Statistical analyses
Statistical signiﬁcance was determined by applying an
independent sample t-test and Pearson’s correlation coef-
ﬁcient to the data, as speciﬁed.
RESULTS
COBRAfor unique toLINE-1 sequence (CU-L1)
Previously, we investigated the methylation of genome-
wide LINE-1s by investigating the methylation status of
two CpG dinucleotides at the 50-end of LINE-1s (4). This
study compares the methylation status of LINE-1s across
diﬀerent loci. Because there are variations in both lengths
and sequences of LINE-1s, we compared methylation
levels of LINE-1s between locations by comparing methy-
lation levels of the same representative CpG dinucleotides:
TaqI positive 80-bp methylated DNA fragments and TasI
positive 98-bp unmethylated DNA fragments (Figure 1A).
We selected a set of 17 full-length LINE-1s located within
introns. All LINE-1s possessed both representative
CpG dinucleotides. Selected LINE-1s (Supplementary
Table S1), a schematic representation of the assay
(Figure 1A) and typical examples of PCR results
(Figure 1B) are shown. We modiﬁed the COBRA protocol
(30) to devise a PCR protocol to evaluate LINE-1 methy-
lation status in the entire genome (COBRALINE-1) and
at a speciﬁc locus (CU-L1) by replacing the LINE-1 for-
ward primer with an oligonucleotide locating on unique
sequence 50 to LINE-1. Brieﬂy, DNA is treated with bisul-
ﬁte to distinguish between methylated and unmethylated
sequences before PCR (32). Treatment with bisulﬁte con-
verts unmethylated cytosines, but not methylated cyto-
sines, to uracils and then thymines after PCR. This
generates detectable methylation-dependent changes in
the restriction pattern of PCR-ampliﬁed LINE-1
sequences (Figure 1A). The modiﬁed DNA was ampliﬁed
by 50-UTR LINE-1 bisulﬁted sequence primers and then
digested with TaqI and TasI restriction enzymes, which
recognize methylated and unmethylated sequences, respec-
tively. The level of LINE-1 methylation in each sample
was calculated by dividing the measured intensity of
TaqI digestible amplicons by the sum of the TasI and
TaqI products (4) (Figure 1A).
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digested fragments, including methylated, unmethylated
and control, which are without candidate CpG restriction
sequences, so that we could check for multiple CpG dinu-
cleotides containing TaqI sites and an unmethylated CpG
containing TasI site. Therefore, the intensities of each
methylated and unmethylated band could be measured
to compare the methylation status among several CpG
nucleotides. Figure 2A and B provides examples of the
positive linear correlation between methylated fragments
from the CU-L1 locations. Direct correlations between
unmethylated fragments were also demonstrated
(Figure 2C and D). Therefore, the methylation levels of
the representative COBRALINE-1 TaqI and TasI sites
represent methylation levels of each LINE-1 in a positive
correlated fashion.
To evaluate the relationship among all of the 50 LINE-1
CpGs, CU-L1 amplicons were cloned and sequenced.
Figure 3 demonstrates examples of CU-L1 sequences.
Direct correlation of methylation levels between CU-L1
and bisulﬁte sequencing can be observed. Both CU-L1
and bisulﬁte sequences demonstrated low L1-LRP2
methylation levels in WSU-HN 6 and 22 cells and high
methylation levels in WSU-HN 26 cells, compared with a
sample of NOE. Therefore, CU-L1 methylation levels
were applied to compare methylation levels between
each DNA sample. The bisulﬁte sequences (Figure 3)
demonstrated that even though they were directly corre-
lated, the methylation statuses of the CpG dinucleotides
from 50 LINE-1 are not equally distributed. We found that
the CpGs around TaqI and TasI COBRALINE-1 digested
sites might be more prone to be demethylation than others
(Figure 3).
Interestingly, even though a universal characteristic of
cancer development is clonal in origin and selective clonal
expansion, bisulﬁte sequencing indicated that LINE-1
methylation patterns of each DNA strand from the same
locus are not identical (Figure 3). This indicates that
LINE-1 methylation may be dynamic. Moreover, there
are mixtures of CU-L1 alleles with distinguishably diﬀer-
ent methylation statuses. For example, the methylation
status of L1-LRP2 can divide the chromosomes of the
cancer cell lines, WSU-HN 6 and 22, into two groups.
The DNA from one group was almost completely
unmethylated and that from the others was partially
methylated (Figure 3). This result may suggest that
LINE-1 hypomethylation in cancer may also be a dynamic
process and either diﬀerent chromosomes or cells may be
unequally inﬂuenced by the global hypomethylation
process.
A general concern with the COBRA method is the mis-
interpretation of cases of a mutation or polymorphism at
a restriction site. For COBRALINE-1, this type of error is
irrelevant because of the vast number of targeted LINE-1
sequences in the genome (4). For CU-L1, we were able to
check for the possibility of a mutation error. If there is a
mutation at the TaqI restriction site, for example TCGA
to TTGA, then the homozygous or heterozygous poly-
morphic sample will result in a false positive as completely
unmethylated for two or one alleles, respectively.
Therefore, CU-L1 methylation levels should dramatically
deviate from the linear correlation of the linked CpGs.
However, striking deviation was rare when methylation
levels between CpGs were compared (Figure 2A).
Nevertheless, because CU-L1 contains several methylated
and unmethylated fragments, alternative sites could be
selected if the density of the representative sites deviated
strikingly from the group (Figure 2A). Moreover, in
normal cells, particularly WBCs, CU-L1s of most loci
usually demonstrated methylation levels in a limited
range without a striking deviation (Figure 4A). In conclu-
sion, mutations or polymorphisms of these CU-L1
Figure 1. COBRA for unique L1 sequence (CU-L1) and COBRA for
genome-wide LINE-1s (COBRALINE1). COBRA was performed as
previously described (30), with some modiﬁcations (4). (A) Schematic
representation of CU-L1 and COBRALINE-1, showing LINE-1
sequence in relation to the 50 unique sequence. AACCG and CCGA
are LINE-1 sequences, following bisulﬁte treatment and PCR,
unmethylated AACCG sequences are converted to AATTG (TasI
site) and methylated sequences are converted from CCGA to TCGA
(TaqI site). The amplicon sizes of CU-L1 are between 300 and 500bp
and for COBRALINE-1 are 160bp. After digestion, COBRALINE-1
yielded two TasI-digested unmethylated L1 sequence fragments of 62
and 98bp and one 80bp TaqI-digested methylated L1 sequence. The
LINE-1 methylation level was calculated as a percentage (the intensity
of methylated LINE-1 divided by the sum of the unmethylated LINE-1
and the TaqI-positive amplicons). CU-L1 usually has additional TaqI
site(s) and AATT sequences; therefore, there are additional methylated,
unmethylated and control bands. Met and unmet are methylated and
unmethylated sequences, respectively. Control bands are digested DNA
fragments without candidate CpG restriction sequences. (B) A typical
example of results from COBRALINE-1 and CU-L1. The ranges of
intensity between methylated and unmethylated bands of CU-L1 were
wider than COBRALINE-1. The unmet, met and control arrows indi-
cate unmethylated, methylated and control LINE1 sequences, respec-
tively. M is a standard size marker. The –ve is dH2O. Several samples
from WSU-HN cells are shown.
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help prevent interpretation errors.
LINE-1methylationlevelsvaryamonglocationsandcelltypes
Our previous study showed that genome-wide LINE-1
methylation levels can be signiﬁcantly diﬀerent among
normal tissue types (4). Moreover, some tissues, such as
the thyroid and esophagus, demonstrated wider ranges
in the methylation level. Here, we compared LINE-1
methylation levels of the 17 loci between NOE and
WBC (Figure 4A). Means of the LINE-1 methylation
levels varied from highly methylated, which was the case
for the L1-PKP4, L1-EPHA3-IVS5, L1-EPHA3-IVS15,
L1-ANTXR2 and L1-COL24A1 fragments, to 24–41%,
which was the case for the L1-PPP2R2B and L1-PKG1
fragments. To support the premise that LINE-1 is com-
pletely methylated, the partial methylation levels of
genome-wide LINE-1s would have to not only be reported
by COBRALINE-1 (4), but also by several other techni-
ques (9,18,33). The lower methylation levels of some of the
Figure 2. Correlation between the bands of CU-L1. Pixel counts of CU-L1 ﬂuorescent intensities from 19 cell lines, 12 WBCs and 12 NOEs are
shown. Examples of two LINE-1 loci are shown. (A and B) Comparison between methylated bands. (C and D) Comparison between unmethylated
bands. (A and C) The L1-EPHA3-IVS5 locus. (B and D) The L1-MGC4217 locus. Each band was named according to the restriction enzymes and
sizes of the digested fragment. Most samples demonstrate a linear correlation. The arrow indicates a striking deviation of the 151-bp TaqI band from
the same sample.
Nucleic Acids Research, 2008, Vol. 36, No. 17 5707CU-L1s proved that not all LINE-1s are completely
methylated in normal cells.
LINE-1 methylation patterns are distinguishable
between NOE and normal WBCs. Even though there
was limited range, when COBRALINE-1s were compared
between NOE and WBCs, they were signiﬁcantly diﬀerent,
P<0.01. Similarly, methylation levels between WBCs and
NOE of some CU-L1 loci were also diﬀerent, such
as in the case of the L1-PPP2R2B (P<10
 9) and
L1-CNTNAP5 (P<10
 10) fragments. Interestingly, in
normal cells, most loci possessed limited ranges, within
4–6% of CU-L1s, while some loci, such as L1-SPOCK3,
demonstrated a wider range of up to 45.46%. The wider
ranges could most frequently be found in NOE rather
than WBCs, such as at the L1-FAM49A, L1-LOC286094
and L1-LRP2 loci. This result is similar to our previous
COBRALINE-1 ﬁnding that the ranges of genome-wide
LINE-1 methylation levels diﬀer across tissues (4).
Characteristics of LINE-1 hypomethylation in cancer
Genome wide LINE-1 methylation levels in cancerous
tissue are lower in variable degrees than in the representa-
tive normal cells (4). To evaluate the cancer-speciﬁc epi-
genetic process in detail, we reported CU-L1s from 17
loci in 11 WSU-HN, HeLa and KB cell lines and com-
pared our ﬁndings with those from a number of NOE
(Figure 4B). LINE-1 hypomethylation, which is a methy-
lation level lower than that in NOE, can be observed in all
loci. However, each locus had a diﬀerent number of sam-
ples with hypomethylation. Three to six samples out of 13
were found to have hypomethylation at the L1-PKP4,
L1-SPOCK3 and L1-MGC42174 loci. On the contrary,
the L1-FAM49A, L1-LOC286094, L1-LRP2, L1-CDH8
and L1-PRKG1 loci demonstrated hypomethylation in
12–13 samples out of 13 samples. Moreover, the level of
hypomethylation varied when comparisons were made
between loci. For example, WSU-HN19 cells had comple-
tely unmethylated L1-COL24A1 and L1-ADAMTS20
loci, but were barely hypomethylated at the L1-EPHA3-
IVS5 and L1-EPHA3-IVS15 loci (Figure 4B). Diﬀerent
CU-L1 levels were observed even if the cells were from
the same origin. WSU-HN30 and WSU-HN31 were two
cell lines derived from the same patient, but from diﬀerent
tissue origins. While most CU-L1 levels were similar,
diﬀerent levels were found at some loci, such as at
L1-EPHA3-IVS15 (Figure 4B). Similar ﬁndings were
found in HeLa and KB cells, which also had a HeLa
contaminant. The hypomethylation level at the
L1-ANTXR2 locus was higher in KB cells than it was in
HeLa. On the contrary, the L1-COL24A1 locus in HeLa
was more hypomethylated than in KB cells (Figure 4B).
The diﬀerences in the CU-L1 methylation pattern between
cell lines were similar to a previous report where a distinc-
tive pattern of LINE-1 methylation was reported in diﬀer-
ent cell lines (6). This result may suggest that the global
hypomethylation pattern of cancer cells can be variable.
It is important to note that hypermethylation of CU-L1
could be observed sporadically, for example, the methyla-
tion level in WSU-HN8at the L1-CNTNAP5 locus
(Figure 4B). Therefore, each LINE-1 locus may have
Figure 3. CU-L1s bisulﬁte sequences. CU-L1s bisulﬁte sequenced
methylated CpG dinucleotides and non-methylated CpGs of each
clone are illustrated with closed and open circles, respectively. The
80-bp (methylated) and 98-bp (unmethylated) TasI-digested fragments
are the 20th and 19th CpGs, respectively. Sample names and CU-L1
methylation levels are shown on the left.
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hypomethylation. This may indicate that LINE-1 hypo-
methylation is dynamic and inﬂuenced in cis by factors
located on the same chromosome.
Similar patterns of LINE-1 methylation can be
observed in vivo. Figure 4C shows the CU-L1 results
from 17 microdissected HNSCC paraﬃn-embedded sec-
tions. Because the quality of DNA derived from these
sample types was poor, not all CU-L1s yield positive
amplicons. Nevertheless, these samples demonstrated
LINE-1 methylation patterns that were similar to those
in the HNSCC cell lines. The speciﬁc characteristics
included a variable degree of frequent LINE-1 hypo-
methylation and sporadic events of L1-CNTNAP5 hyper-
methylation (Figure 4C).
We evaluated the directions of relationships between
methylation levels of two that were between genome-wide
and a speciﬁc locus or between two loci. Correlations are
reported as Pearson correlation coeﬃcients (r). The
r-values between  0.5 and 0.5 were considered not
signiﬁcant. The multiple white spots in Figure 5 represent
r-values between the COBRAs, listed on the x-axis, and
the other r-values. We observed positive correlations
between LINE-1 methylation levels between genome-
wide and a speciﬁc locus or between two loci more fre-
quently in WSU-HN than in NOE cells. This is demon-
strated by the fact that most r-values between the LINE-1s
of WSU-HN cells, but not of NOE cells, are frequently
closer to one (Figure 5A and B). Hence, methylation
levels of LINE-1s in cancer cells may result from a gen-
eralized process of global demethylation. However,
methylation of certain loci, such as L1-SPOCK3
and L1-PKP4, did not have a positive correlation
with their cancer genome or other loci (Figure 5A).
Figure 4. CU-L1 methylation levels. (A) NOE and WBC, (B) NOE and epithelial cell lines, (C) NOE and HNSCC. Each dot represents means SD
each CU-L1 methylation level. Dashed and solid lines connect the measurements from the same samples.
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many samples (Figure 4B). Therefore, they may be less
inﬂuenced by the global hypomethylation process. The
highest correlation value observed in cancerous cells,
was between the two LINE-1s inserted in the same gene,
L1-EPHA3-IVS5 and L1-EPHA3-IVS15 (P<10
 16;
Pearson r=0.913) (Figure 5A). These characteristics of
CU-L1 methylation levels suggest that loss of LINE-1
methylation in cancers, in addition to being a result of
genome-wide hypomethylation, may also be inﬂuenced
by locus-speciﬁc pressure.
DISCUSSION
Methylation patterns of LINE-1s in diﬀerent normal
tissue types and hypomethylation characteristics in many
types of epithelial cancers have been previously reported
(4–18). To our knowledge, this is the ﬁrst report to demon-
strate methylation patterns of LINE-1s at diﬀerent geno-
mic locations. It is surprising that even though LINE-1s
are repetitive sequences, methylation levels of LINE-1s
among diﬀerent loci can be diﬀerent. In normal cells,
some loci possess high methylation levels, whereas many
loci are only partially methylated. This suggests that
cis-elements, or factors on the same chromosome near
each LINE-1, may inﬂuence the epigenetic modiﬁcation.
LINE-1 methylation levels of some loci represent a tissue-
speciﬁc pattern, as shown by the diﬀerent levels between
NOE and WBC. Interestingly, Eller and colleagues (34)
demonstrated that LINE-1 elements are frequently
excluded from housekeeping regions. Moreover, hyper-
methylation of LINE-1s has been reported during abnor-
mal overgrowth and diﬀerentiation of human placenta
(11). It is therefore possible that LINE-1 methylation is
associated with tissue-speciﬁc phenotypes of the cells in
relation to the genome function in cis. Finally, in some
regions (e.g. L1-SPOCK3), this epigenetic control may be
a dynamic process. Wider ranges of methylation levels
could be observed with a greater number of LINE-1 loci
in NOE than in WBC. Interestingly, we previously found
intermediate ranges of genome-wide LINE-1 methylation
levels in head and neck squamous cells and wider ranges in
esophageal and thyroid tissues (4).
LINE-1 hypomethylation is a common epigenetic pro-
cess in cancer that may progressively evolve during the
multistage carcinogenesis process (4,5,7,12). The underly-
ing mechanism of this process is not known. Because the
methylation levels of most LINE-1 loci in cancerous cells
are positively correlated with each other and on a genome-
wide level, we concluded that the mechanism leading to
global hypomethylation is a generalized process that
simultaneously inﬂuences dispersed loci. Our experiments,
however, have demonstrated that the locus-speciﬁc epige-
netic modiﬁcations of some loci may also be related to
carcinogenesis. Evidence that supports this hypothesis
includes the data that show diﬀerent hypomethylation
incidences from diﬀerent LINE-1 loci, the direct associa-
tion between the two LINE-1s in EPHA3 introns and
hypermethylation of some loci, such as L1-CNTNAP5,
in some HNSCCs. In conclusion, even though global
hypomethylation processes can generally and progres-
sively deplete LINE-1 methylation levels, locus-speciﬁc
methylation of LINE-1s can diﬀerentially be inﬂuenced
by carcinogenic processes depending on where the parti-
cular LINE-1s are located in the genome.
The level of LINE-1 hypomethylation is positively asso-
ciated with how the tumor progresses (4,5,7,12).
Consequently, the potential roles of a PCR-based LINE-
1 methylation analysis for cancer diagnosis has been eval-
uated by several studies (8–10,12,13). Diﬀerential methy-
lation levels of normal tissues, however, limit the utility
of COBRALINE-1. For example, the application of
COBRALINE-1 to analyze circulating free cell DNA
should be limited because serum DNA contains a mixture
Figure 5. COBRALINE-1 and CU-Ls correlation. Pearson correlation coeﬃcient values between LINE-1 and genome-wide loci of (A) WSU-HN
cells and (B) NOE cells. Arrows indicate an association between loci L1-EPHA3-IVS5 and L1-EPHA3-IVS15.
5710 Nucleic Acids Research, 2008, Vol. 36, No. 17of DNA released from normal and cancerous cells (35).
The cancer-induced global hypomethylation diﬀerentially
inﬂuences each LINE-1 locus depending on their loca-
tions. Moreover, variations of methylation levels in
normal cells occur speciﬁcally at some loci. Consequently,
since there are a vast number of LINE-1s, researchers can
test and select for LINE-1 loci that yield speciﬁc informa-
tion related to cancer development. The CU-L1 methyla-
tion levels may therefore be an important tool for cancer
diagnosis in the future.
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